PowerShares Bio&Genome ETF (PBE) Buy, Sell or…

PowerShares Bio&Genome ETF (PBE)

84.10

-0.72 (0.85%)

as of Jun 12, 2026, 8:00:00 pm Market Open.

1 watching

PAST TOP PICK

(A Top Pick Feb 2/10. Up 19.34%.) Bio & Genome ETF. For 10 years biotech has been doing nothing but tech has been dong lots. Expects there will be a rediscovery of the space. Safe way to play the pharmacy space.

PAST TOP PICK

(A Top Pick Feb 2/10. Up 14.99%.) Still likes. Thinks its time is due.

TOP PICK

Bio & Genome ETF. Expect there will be massive changes in nanotechnology, stem cell research, etc. in the next 4 to 5 years. This is the only way to buy all the very small NASDAQ traded names and one of them is going to hit it rich.

BUY

This is a basket approach to biotechs and should be considered as a long-term hold. Good price.

PAST TOP PICK

(A Top Pick Feb 23/06. Down 16%.) When the market gets nervous, speculative stocks get hit. A long-term holding because it is a basket of biotech companies. Over time, it should give investors a good long term return.

PAST TOP PICK

(A Top Pick Feb 25/06. Down 6%.) A long-term hold. This is a basket of biotech shares.

TOP PICK

This is a way of getting into biotech without having to invest in a single company.

Showing 1 to 7 of 7 entries

PowerShares Bio&Genome ETF (PBE) Frequently Asked Questions

What is PowerShares Bio&Genome ETF stock symbol?

PowerShares Bio&Genome ETF is a American stock, trading under the symbol PBE (previously PBE-N on Stockchase) on the NYSE Arca (PBE). It is usually referred to as AMEX:PBE or PBE

Is PowerShares Bio&Genome ETF a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on PBE (previously PBE-N on Stockchase) on Stockchase. Read the latest expert commentary for PowerShares Bio&Genome ETF.

Is PowerShares Bio&Genome ETF a good investment or a top pick?

PowerShares Bio&Genome ETF was recommended as a Top Pick by David Driscoll on 2006-02-23. Read the latest stock experts ratings for PowerShares Bio&Genome ETF.

Why is PowerShares Bio&Genome ETF stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for PowerShares Bio&Genome ETF.

Is PowerShares Bio&Genome ETF worth watching?

PowerShares Bio&Genome ETF is covered by Stockchase experts and is worth watching.

What is PowerShares Bio&Genome ETF stock price?

On 2026-06-12, PowerShares Bio&Genome ETF (PBE) stock closed at a price of $84.10.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

PowerShares Bio&Genome ETF (PBE)